German AML Cooperative Group: Clinical Trials

1 trial sponsored by German AML Cooperative Group, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow German AML Cooperative Group: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic
Arsenic trioxide, Trisenox - Relapsed Acute Promyelocytic Leukemia, Refractory Acute Promyelocytic Leukemia
Phase 4UnknownGerman AML Cooperative Group302005-01-012007-10-23

Conditions studied

Leukemia, Promyelocytic, Acute (1)  ·  Recurrence (1)

Interventions

Arsenic Trioxide (1)

Countries

Germany (1)

Top investigators

Eva Lengfelder, MD, PhD (1)

Results publications

PMID 25528350